[1. E. J. Benjamin, P. Muntner, A. Alonso, M. S. Bittencourt, C. W. Callaway, A. P. Carson, A. M. Chamberlain, A. R. Chang, S. Cheng, S. R. Das, F. N. Delling, L. Djousse, M. S. V. Elkind, J. F. Ferguson, M. Fornage, L. C. Jordan, S. S. Khan, B. M. Kissela, K. L. Knutson, T. W. Kwan, D. T. Lackland, T. T. Lewis, J. H. Lichtman, C. T. Longenecker, M. S. Loop, P. L. Lutsey, S. S. Martin, K. Matsushita, A. E. Moran, M. E. Mussolino, M. O’Flaherty, A. Pandey, A. M. Perak, W. D. Rosamond, G. A. Roth, U. K. A. Sampson, G. M. Satou, E. B. Schroeder, S. H. Shah, N. L. Spartano, A. Stokes, D. L. Tirschwell, C. W. Tsao, M. P. Turakhia, L. B. VanWagner, J. T. Wilkins, S. S. Wong and S. S. Virani, Heart disease and stroke statistics-2019 update: A report from the American Heart Association, Circulation139 (2019) e56–e528; https://doi.org/10.1161/cir.000000000000065910.1161/CIR.0000000000000659]Search in Google Scholar
[2. M. J. Budoff, S. Achenbach, R. S. Blumenthal, J. J. Carr, J. G. Goldin, P. Greenland, A. D. Guerci, J. A. Lima, D. J. Rader, G. D. Rubin, L. J. Shaw and S. E. Wiegers, Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology, Circulation114 (2006) 1761–1791; https://doi.org/10.1161/circulationaha.106.17845810.1161/CIRCULATIONAHA.106.178458]Search in Google Scholar
[3. P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, F. G. Kushner, M. S. Lauer, L. J. Shaw, S. C. Smith, A. J. Taylor, W. S. Weintraub and N. K. Wenger, 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation122 (2010) e584–e636; https://doi.org/10.1161/cir.0b013e3182051b4c10.1161/CIR.0b013e3182051b4c]Search in Google Scholar
[4. D. L. Bhatt, Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction? Nat. Clin. Pract. Cardiovasc. Med.3 (2006) 182–183; https://doi.org/10.1038/ncpcardio050810.1038/ncpcardio0508]Search in Google Scholar
[5. J. Sullivan and N. Amarshi, Dual antiplatelet therapy with clopidogrel and aspirin, Am. J. Health Syst. Pharm.65 (2008) 1134–1143; https://doi.org/10.2146/ajhp06066210.2146/ajhp060662]Search in Google Scholar
[6. A. Algra and J. van Gijn, Is clopidogrel superior to aspirin in secondary prevention of vascular disease? Curr. Control Trials Cardiovasc. Med.1 (2000) 143–145; https://doi.org/10.1186/cvm-1-3-14310.1186/CVM-1-3-143]Search in Google Scholar
[7. A. Grzybowski and K. Pietrzak, Albert Szent-Györgyi (1893-1986): the scientist who discovered vitamin C, Clin. Dermatol.31 (2013) 327–331; https://doi.org/10.1016/j.clindermatol.2012.08.00110.1016/j.clindermatol.2012.08.001]Search in Google Scholar
[8. B. Havsteen, Flavonoids, a class of natural products of high pharmacological potency, Biochem. Pharmacol.32 (1983) 1141–1148; https://doi.org/10.1016/S0163-7258(02)00298-X10.1016/S0163-7258(02)00298-X]Search in Google Scholar
[9. K. Janssen, R. P. Mensink, F. J. Cox, J. L. Harryvan, R. Hovenier, P. C. Hollman and M. B. Katan, Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study, Am. J. Clin. Nutr.67 (1998) 255–262; https://doi.org/10.1093/ajcn/67.2.25510.1093/ajcn/67.2.2559459373]Search in Google Scholar
[10. U. T. Seyfert, H. Haubelt, A. Vogt and P. Hellstern, Variables influencing Multiplate whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals, Platelets18 (2007) 199–206. https://doi.org/10.1080/0953710060094427710.1080/0953710060094427717497431]Search in Google Scholar
[11. M. Bojić, Ž. Debeljak, M. Medić-Šarić and M. Tomičić, Interference of selected flavonoid aglycons in platelet aggregation assay, Clin. Chem. Lab. Med.50 (2012) 1403–1408; https://doi.org/10.1515/cclm-2011-096010.1515/cclm-2011-0960]Search in Google Scholar
[12. M. Bojić, Ž. Debeljak, M. Tomičić, M. Medić-Šarić and S. Tomić, Evaluation of antiaggregatory activity of flavonoid aglycone series, Nutr. J.10 (2011) Article ID 73 (8 pages); https://doi.org/10.1186/1475-2891-10-7310.1186/1475-2891-10-73]Search in Google Scholar
[13. A. Calatzis, R. M. Loreth and M. Spannagl, Multiplate®Platelet Function Analysis – Application and Interpretation, Dynabyte GmbH, Munich 2006.]Search in Google Scholar
[14. M. Bijak, A. Sut, A. Kosiorek, J. Saluk-Bijak and J. Golanski J, Dual anticoagulant/antiplatelet activity of polyphenolic grape seeds extract, Nutrients11 (2019) Article ID 93 (9 pages); https://doi.org/10.3390/nu1101009310.3390/nu11010093]Search in Google Scholar
[15. A. Meshkini and M. Tahmasbi, Antiplatelet aggregation activity of walnut hull extract via suppression of reactive oxygen species generation and caspase activation, J. Acupunct. Meridian Stud.10 (2017) 193–203; https://doi.org/10.1016/j.jams.2017.02.00710.1016/j.jams.2017.02.007]Search in Google Scholar
[16. E. K. Yoon, S. K. Ku, W. Lee, S. Kwak, H. Kang, B. Jung and S. Bae, Antitcoagulant and antiplatelet activities of scolymoside, BMB Rep.48 (2015) 577–582; https://doi.org/10.5483/BMBRep.2015.48.10.04410.5483/BMBRep.2015.48.10.044]Search in Google Scholar
[17. S. K. Ku and J. S. Bae, Antithrombotic activities of wogonin and wogonoside via inhibiting platelet aggregation, Fitoterapia98 (2014) 27–35; https://doi.org/10.1016/j.fitote.2014.07.00610.1016/j.fitote.2014.07.006]Search in Google Scholar
[18. W. Lee W and J. S. Bae, Antithrombotic and antiplatelet activities of vicenin-2, Blood Coagul. Fibrinolysis26 (2015) 628–634; https://doi.org/10.1097/MBC.000000000000032010.1097/MBC.0000000000000320]Search in Google Scholar
[19. A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina and F. Castelli, Flavonoids as antioxidant agents: importance of their interaction with biomembranes, Free Radic. Biol. Med.19 (1995) 481‒486; https://doi.org/10.1016/0891-5849(94)00240-K10.1016/0891-5849(94)00240-K]Search in Google Scholar
[20. A. Polette, D. Lemaitre, M. Lagarde and E. Véricel, n-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins, Thromb. Haemost.75 (1996) 945‒949; https://doi.org/10.1055/s-0038-165039910.1055/s-0038-1650399]Search in Google Scholar
[21. T. J. Neiva, L. Morais, M. Polack, C. M. Simões and E. A. D’Amico, Effects of catechins on human blood platelet aggregation and lipid peroxidation, Phytother. Res.13 (1999) 597‒600; https://doi.org/10.1002/(SICI)1099-1573(199911)13:7<597::AID-PTR512>3.0.CO;2-Z10.1002/(SICI)1099-1573(199911)13:7<597::AID-PTR512>3.0.CO;2-Z]Search in Google Scholar
[22. S. L. Hwang and G. C. Yen, Modulation of Akt, JNK, and p38 activation is involved in citrus flavonoid-mediated cytoprotection of PC12 cells challenged by hydrogen peroxide, J. Agric. Food. Chem.57 (2009) 2576‒2582; https://doi.org/10.1021/jf803360710.1021/jf803360719222219]Search in Google Scholar
[23. F. Orallo, E. Alvarez, H. Basaran and C. Lugnier, Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin, Naunyn. Schmiedebergs Arch. Pharmacol.370 (2004) 452‒463; https://doi.org/10.1007/s00210-004-0994-610.1007/s00210-004-0994-615599707]Search in Google Scholar
[24. T. P. Dew, A. J. Day and M. R. Morgan, Xanthine oxidase activity in vitro: effects of food extracts and components, J. Agric. Food Chem.53 (2005) 6510‒6515; https://doi.org/10.1021/jf050716j10.1021/jf050716j16076142]Search in Google Scholar
[25. D. S. Chou, J. J. Lee, G. Hsiao, C. Y. Hsieh, Y. J. Tsai, T. F. Chen and J. R. Sheu, Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study, J. Agric. Food Chem.55 (2007) 649‒655; https://doi.org/10.1021/jf062584f10.1021/jf062584f17263456]Search in Google Scholar
[26. Y. R. Jin, X. H. Han, Y. H. Zhang, J. J. Lee, Y. Lim, J. H. Chung and Y. P. Yun, Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity, Atherosclerosis194 (2007) 144‒152; https://doi.org/10.1016/j.atherosclerosis.2006.10.01110.1016/j.atherosclerosis.2006.10.01117092506]Search in Google Scholar
[27. O. A. Ogunbayo, R. M. Harris, R. H. Waring, C. J. Kirk and F. Michelangeli, Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by flavonoids: a quantitative structure-activity relationship study, IUBMB Life60 (2008) 853‒858; https://doi.org/10.1002/iub.13210.1002/iub.13218785622]Search in Google Scholar
[28. G. P. Hubbard, S. Wolffram, J. A. Lovegrove and J. M. Gibbins, Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans, J. Thromb. Haemost.2 (2004) 2138‒2145. https://doi.org/10.1111/j.1538-7836.2004.01067.x10.1111/j.1538-7836.2004.01067.x15613018]Search in Google Scholar
[29. B. Wright, L. A. Moraes, C. F. Kemp, W. Mullen, A. Crozier, J. A. Lovegrove and J. M. Gibbins, A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids, Br. J. Pharmacol.159 (2010) 1312‒1325; https://doi.org/10.1111/j.1476-5381.2009.00632.x10.1111/j.1476-5381.2009.00632.x284893520148891]Search in Google Scholar
[30. L. Liu, D. M. Xu and Y. Y. Cheng, Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells, J. Agric. Food Chem.56 (2008) 824‒829; https://doi.org/10.1021/jf072300710.1021/jf072300718197618]Search in Google Scholar
[31. M. Dell’Agli, O. Maschi, G. V. Galli, R. Fagnani, E. Dal Cero, D. Caruso and E. Bosisio, Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase, Br. J. Nutr.99 (2008) 945‒951; https://doi.org/10.1017/S000711450783747010.1017/S000711450783747017927845]Search in Google Scholar
[32. J. H. Lee and G. H. Kim, Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis, J. Food Sci.75 (2010) H212‒H217; https://doi.org/10.1111/j.1750-3841.2010.01755.x10.1111/j.1750-3841.2010.01755.x]Search in Google Scholar
[33. J. Vibes, B. Lasserre, J. Gleye and C. Declume, Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads, Prostaglandins Leukot. Essent. Fatty Acids50 (1994) 173‒175; https://doi.org/10.1016/0952-3278(94)90141-410.1016/0952-3278(94)90141-4]Search in Google Scholar
[34. I. Babić, M. Bojić, Ž. Maleš, R. Zadro, K. Gojčeta, I. Duka, H. Rimac and I. Jukić, Influence of flavonoids’ lipophilicity on platelet aggregation, Acta Pharm. 69 (2019) (this issue).10.2478/acph-2019-004031639087]Search in Google Scholar
[35. M. L. Liang, X. W. Da, A. D. He, G. Q. Yao, W. Xie, G. Liu, J. Z. Xiang and Z. Y. Ming, Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function, Sci. Rep.5 (2015) 11142 (11 pages); https://doi.org/10.1038/srep1114210.1038/srep11142446191926059557]Search in Google Scholar
[36. Ž. Maleš, A. Antolić, I. Babić, S. Jurić and M. Bojić, Quantitative analysis of phenolic acids and anti-platelet activity of Melissa officinalis leaf extracts, Nat. Prod. Commun.12 (2017) 93–94; https://doi.org/10.1177/1934578X170120012610.1177/1934578X1701200126]Search in Google Scholar
[37. O. Estrada, W. Contreras, G. Acha, E. Lucena, W. Venturini, A. Cardozo and C. Alvarado-Castillo, Chemical constituents from Licania cruegeriana and their cardiovascular and antiplatelet effects, Molecules19 (2014) 21215–21225; https://doi.org/10.3390/molecules19122121510.3390/molecules191221215627079025525822]Search in Google Scholar
[38. R. Kasimu, Z. Fan, X. Wang, J. Hu, P. Wang and J. Wang, Anti-platelet aggregation activities of different fractions in leaves of Apocynum venetum L., J. Ethnopharmacol.168 (2015) 116–121; https://doi.org/10.1016/j.jep.2015.03.0130378-8741]Search in Google Scholar
[39. J. Y. Ro, J. H. Ryu, H. J. Park and H. J. Cho, Onion (Allium cepa L.) peel extract has anti-platelet effects in rat platelets, Springerplus4 (2015) 17 (8 pages); https://doi.org/10.1186/s40064-015-0786-010.1186/s40064-015-0786-0430360225628983]Search in Google Scholar
[40. A. Antolić, Ž. Maleš, M. Tomičić and M. Bojić, The effect of short-toothed and Dalmatian sage extracts on platelet aggregation, Food Technol. Biotech.56 (2018) 265–269; https://doi.org/10.17113/ftb.56.02.18.547410.17113/ftb.56.02.18.5474611799530228801]Search in Google Scholar
[41. A. D. Assefa, E. Y. Ko, S. H. Moon and Y. S. Keum, Antioxidant and antiplatelet activities of flavonoid-rich fractions of three citrus fruits from Korea, 3 Biotech. 6 (2016) 109 (10 pages); https://doi.org/10.1007/s13205-016-0424-810.1007/s13205-016-0424-8483776428330179]Search in Google Scholar
[42. M. Bojić, A. Antolić, M. Tomičić, Ž. Debeljak and Ž. Maleš, Propolis ethanolic extracts reduce adenosine diphosphate induced platelet aggregation determined on whole blood, Nutr. J.17 (2018) 52 (8 pages); https://doi.org/10.1186/s12937-018-0361-y10.1186/s12937-018-0361-y595265029759064]Search in Google Scholar
[43. C. H. Lescano, F. Freitas de Lima, C. B. Mendes-Silvério, A. F. O. Justo, D. da Silva Baldivia, C. P. Vieira, E. J. Sanjinez-Argandoña, C. A. L. Cardoso, F. Z. Mónica and I. Pires de Oliveira, Effect of polyphenols from Campomanesia adamantium on platelet aggregation and inhibition of cyclooxygenases: Molecular docking and in vitro analysis, Front. Pharmacol.9 (2018) 617 (13 pages); https://doi.org/10.3389/fphar.2018.0061710.3389/fphar.2018.00617]Search in Google Scholar
[44. A. Mira, W. Alkhiary and K. Shimizu, Antiplatelet and anticoagulant activities of Angelica shikokiana extract and its isolated compounds, Clin. Appl. Thromb. Hemost.23 (2017) 91–99; https://doi.org/10.1177/107602961559587910.1177/1076029615595879]Search in Google Scholar
[45. A. A. Boligon, V. C. Pimentel, M. D. Bagatini and M. L. Athayde, Effect of Scutia buxifolia Reissek in nucleotidase activities and inhibition of platelet aggregation, J. Nat. Med.69 (2015) 46–54; https://doi.org/10.1007/s11418-014-0858-410.1007/s11418-014-0858-4]Search in Google Scholar
[46. S. U. Kwon, H. Y. Lee, M. Xin, S. J. Ji, H. K. Cho, D. S. Kim, D. K. Kim and Y. M. Lee, Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation, Blood Coagul. Fibrin.27 (2016) 141–146; https://doi.org/10.1097/MBC.000000000000039410.1097/MBC.0000000000000394]Search in Google Scholar
[47. M. S. Rajput, N. Balekar and D. K. Jain, Inhibition of ADP-induced platelet aggregation and involvement of non-cellular blood chemical mediators are responsible for the antithrombotic potential of the fruits of Lagenaria siceraria, Chin. J. Nat. Med.12 (2014) 599–606; https://doi.org/10.1016/S1875-5364(14)60091-110.1016/S1875-5364(14)60091-1]Search in Google Scholar
[48. J. Rywaniak, B. Luzak, A. Podsedek, D. Dudzinska, M. Rozalski and C. Watala, Comparison of cytotoxic and anti-platelet activities of polyphenolic extracts from Arnica montana flowers and Juglans regia husks, Platelets26 (2015) 168–176; https://doi.org/10.3109/09537104.2014.89497010.3109/09537104.2014.89497024679412]Search in Google Scholar
[49. R. Zamora-Ros, V. Knaze, L. Luján-Barroso, N. Slimani, I. Romieu, V. Fedirko, M. S. Magistris, U. Ericson, P. Amiano, A. Trichopoulou, V. Dilis, A. Naska, D. Engeset, G. Skeie, A. Cassidy, K. Overvad, P. H. M. Peeters, J. M. Huerta, M.-J. Sánchez, J. R. Quirós, C. Sacerdote, S. Grioni, R. Tumino, G. Johansson, I. Johansson, I. Drake, F. L. Crowe, A. Barricarte, R. Kaaks, B. Teucher, H. B. Bueno-de-Mesquita, C. T. M. Rossum, T. Norat, D. Romaguera, A.-C. Vergnaud, A. Tjønneland, J. Halkjær, F. Clavel-Chapelon, M.-C. Boutron-Ruault, M. Touillaud, S. Salvini, K.-T. Khaw, N. Wareham, H. Boeing, J. Förster, E. Riboli and C. A. González, Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort, Br. J. Nutr.106 (2011) 1915–1925; https://doi.org/10.1017/S000711451100239X10.1017/S000711451100239X21679483]Search in Google Scholar
[50. P. C. Hollman, J. H. de Vries, S. D. van Leeuwen, M. J. Mengelers and M. B. Katan, Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers, Am. J. Clin. Nutr.62 (1995) 1276‒1282; https://doi.org/10.1093/ajcn/62.6.127610.1093/ajcn/62.6.12767491892]Search in Google Scholar
[51. C. Manach, G. Williamson, C. Morand, A. Scalbert and C. Rémésy, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, Am. J. Clin. Nutr.81 (2005) 230S–242S; https://doi.org/10.1093/ajcn/81.1.230S10.1093/ajcn/81.1.230S15640486]Search in Google Scholar
[52. K. S. Krogholm, L. Bredsdorff, P. Knuthsen, J. Haraldsdóttir and S. E. Rasmussen, Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet, Eur. J. Clin. Nutr.64 (2010) 432–435; http://doi.org/10.1038/ejcn.2010.610.1038/ejcn.2010.620125185]Search in Google Scholar
[53. I. Palomo, A. Concha-Meyer, M. Lutz, M. Said, B. Sáez, A. Vásquez and E. Fuentes, Chemical characterization and antiplatelet potential of bioactive extract from tomato pomace (byproduct of tomato paste), Nutrients11 (2019) Article ID 456 (10 pages); https://doi.org/10.3390/nu1102045610.3390/nu11020456641268430813256]Search in Google Scholar
[54. T. Nickel, K. Lackermair, J. Scherr, A. Calatzis, M. Vogeser, H. Hanssen, G. Waidhauser, U. Schönermark, H. Methe, S. Horster, U. Wilbert-Lampen and M. Halle, Influence of high polyphenol beverage on stress-induced platelet activation, J. Nutr. Health Aging20 (2016) 586–593; https://doi.org/10.1007/s12603-016-0697-y10.1007/s12603-016-0697-y27273347]Search in Google Scholar
[55. K. Thompson, H. Hosking, W. Pederick, I. Singh and A. B. Santhakumar, The effect of anthocyanin supplementation in modulating platelet function in sedentary population: a randomised, double-blind, placebo-controlled, cross-over trial, Br. J. Nutr.118 (2017) 368–374; https://doi.org/10.1017/S000711451700212410.1017/S000711451700212428901892]Search in Google Scholar
[56. J. J. Peterson, J. T. Dwyer, P. F. Jacques and M. L. McCullough, Do flavonoids reduce cardiovascular disease incidence or mortality in US and European populations? Nutr. Rev.70 (2012) 491–508; https://doi.org/10.1111/j.1753-4887.2012.00508.x10.1111/j.1753-4887.2012.00508.x413017422946850]Search in Google Scholar
[57. Z. M. Wang, D. Zhao, Z. L. Nie, H. Zhao, B. Zhou, W. Gao, L. S. Wang and Z. J. Yang, Flavonol intake and stroke risk: a meta-analysis of cohort studies, Nutrition30 (2014) 518–523; https://doi.org/10.1016/j.nut.2013.10.00910.1016/j.nut.2013.10.00924342529]Search in Google Scholar